Skip to main content
  1. Market Insights
  2. Health
  3. Pharmaceuticals

Immunosuppressants - Taiwan

Taiwan
  • In Taiwan, the Immunosuppressants market is expected to witness a significant increase in revenue.
  • By 2024, it is projected to reach US$134.50m.
  • Furthermore, a steady annual growth rate (CAGR 2024-2029) of 15.13% is anticipated, leading to a market volume of US$272.00m by 2029.
  • In terms of global comparison, it is worth noting that United States will generate the highest revenue in the Immunosuppressants market.
  • In 2024, United States is projected to generate a substantial revenue of US$35.47bn.
  • Taiwan's immunosuppressants market is experiencing steady growth due to increasing demand for organ transplantation and a rising prevalence of autoimmune diseases.

Definition:
The Immunosuppressants market covers drugs which suppress the immune response. These remedies are used in different therapy areas, mainly to treat auto-immune diseases, such as psoriasis. Anti-rejection drugs administered after organ transplantations are also included in this market. Monoclonal antibodies are an important type of immunosuppressant.

Additional information:
Market values represent the revenues generated by manufacture prices paid to primary vendors, either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), companies (B2B), and governments (B2G).

Company examples: Johnson & Johnson, Sanofi, Novartis

In-Scope

  • Drugs to suppress the immune response
  • Immunosuppressants to treat auto-immune diseases, such as psoriasis
  • Anti-rejection drugs

Out-Of-Scope

  • Multiple sclerosis drugs
  • Anti-rheumatic drugs
  • Immuno-oncology drugs
  • Antivirals
  • Antibiotics
  • Corticosteroids
  • HIV drugs
Immunosuppressants: market data & analysis - Cover

Market Insights report

Immunosuppressants: market data & analysis

Study Details

    Revenue

    Notes: Data shown is using current exchange rates and reflects market impacts of the Russia-Ukraine war.

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Notes: The chart “Comparable Estimates” shows the forecasted development of the selected market from different sources. Please see the additional information for methodology and publication date.

    Most recent update: Mar 2024

    Analyst Opinion

    Taiwan, known for its technological advancements and efficient healthcare system, has been witnessing a steady growth in the Immunosuppressants market.

    Customer preferences:
    Patients in Taiwan suffering from autoimmune diseases such as rheumatoid arthritis, lupus, and psoriasis are the primary consumers of Immunosuppressants. The increasing awareness about these diseases and the availability of advanced treatment options have led to a rise in demand for Immunosuppressants in the country.

    Trends in the market:
    The Immunosuppressants market in Taiwan has been witnessing a shift towards biologic drugs, which are more effective in treating autoimmune diseases. The market has also been witnessing the entry of new players, which has intensified the competition. The shift towards biologic drugs and the growing competition have led to a decrease in the prices of Immunosuppressants in Taiwan.

    Local special circumstances:
    Taiwan has a well-established healthcare system, which provides universal health coverage to its citizens. The government has been taking initiatives to promote the use of generic drugs to reduce healthcare costs. This has led to an increase in the use of generic Immunosuppressants in Taiwan.

    Underlying macroeconomic factors:
    The aging population in Taiwan has been a major driver of the Immunosuppressants market. As the population ages, the prevalence of autoimmune diseases increases, leading to a rise in demand for Immunosuppressants. The increasing healthcare expenditure in Taiwan has also been a contributing factor to the growth of the Immunosuppressants market. In conclusion, the Immunosuppressants market in Taiwan is witnessing a shift towards biologic drugs and an increase in the use of generic drugs. The aging population and the increasing healthcare expenditure in the country are expected to drive the growth of the market in the coming years.

    Global Comparison

    Most recent update: Jun 2024

    Source: Statista Market Insights

    Methodology

    Data coverage:

    Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

    Modeling approach / Market size:

    Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

    Forecasts:

    In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

    Additional notes:

    Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.

    Health

    Access more Market Insights on Health topics with our featured report

    Immunosuppressants: market data & analysis - BackgroundImmunosuppressants: market data & analysis - Cover

    Key Market Indicators

    Notes: Based on data from IMF, World Bank, UN and Eurostat

    Most recent update: Sep 2024

    Source: Statista Market Insights

    Explore more high-quality data on related topic

    Global pharmaceutical industry - statistics & facts

    The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.
    More data on the topic

    Contact

    Get in touch with us. We are happy to help.